Acting Assistant ProfessorMedicine Director of GMS Addiction Medicine Program, VA Puget Sound Healthcare SystemRelated Links: TwitterFaculty Information Biography Education & Training: MD, high honorsUniversity of WashingtonSeattle, WA2010–2014 Residency in Internal MedicineUniversity of Pittsburgh School of MedicinePittsburgh, PA2014–2017 Chief Resident in Internal MedicineUniversity of PittsburghPittsburgh, PA2017–2018 MS, Clinical ResearchUniversity of PittsburghUniversity of Pittsburgh2018–2020 Clinician Researcher FellowUniversity of PittsburghPittsburgh, PA2018–2020 Honors: Alpha Omega Alpha (AOA) Honor Society, University of Washington 2013 Gold Humanism Honor Society, University of Washington 2013 Society for Pediatric Pathology Gilbert-Barness Award2014 Wyoming Medical Society Outstanding Graduate Scholarship Award2014 First Place Research Poster, University of Pittsburgh Internal Medicine Research Day2017 Thomas O’Toole Senior Resident Award for “Outstanding Care for Vulnerable Populations”2017 University of Pittsburgh Medical Center Medical Education Plenary Award 2018 Fellow, American Society of Addiction Medicine 2021 Contact Email: amy.kennedy@va.gov Research & Clinical Interests Research Interests: Implementation of evidence-based treatment of substance use disorders within primary care Low-barrier access to medications for addiction treatment Curricular development for addiction medicine within graduate medical education Clinical Interests: Primary care for people experiencing homelessness Primary care for people living with HIV Treatment of substance use disorders Publications Publications: Kennedy AJ, McNeil M, Hamm M, de Abril Cameron F, Carter A. Internal Medicine Resident Perceptions of Patients with Substance Use Disorder After Attending a Mutual Support Group Meeting. Journal of General Internal Medicine; 29 Oct 2019, 35(3):918-921. Kennedy AJ, Bakalov V, Reyes-Uribe L, Kensler C, Connor S, Bui T, Radomski T. Free Clinic Patients’ Perceptions and Barriers to Applying for Health Insurance After Implementation of the Affordable Care Act. Journal of Community Health; 2020; 45: 492-500. Kennedy AJ, de April Cameron F, Hassan I, Goabo V, Fisk S, Ho K, Edelman J, Hamm M, Merlin J. Barriers and Facilitators to Providing HIV Pre-Exposure Prophylaxis among Buprenorphine Prescribers: A Qualitative Study. Journal of Addiction Medicine. September 8, 2020. Volume published ahead of print. Kennedy AJ, Lombardi K, Fruehstorfer G, Hamm M, McNeil M, Carter A. Words Medicine Residents Use to Describe Substance Use Disorders After Attending a Mutual Support Group Meeting. Journal of General Internal Medicine. January 6, 2021. Kennedy AJ, Wessel CB, Levine R, Downer K, Raymond M, Osakue D, Hassan I, Merlin JS, Liebschutz JM. Factors Associated with Long-term Retention in Buprenorphine-Based Addiction Treatment Programs: A Systematic Review. Journal of General Internal Medicine. January 19, 2021. Online ahead of print. Kennedy AJ, McGinnis KA, Merlin JS, Edelman EJ, Gordon AJ, Korthuis PT, Skanderson M, Williams EC, Wyse J, Oldfield B, Bryant K, Justice A, Fiellin D, Kraemer KL. Impact of intensity of behavioral treatment, with and without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV. Journal of Substance Abuse and Treatment. 2021 May 29;132:108509 Paul N, Kennedy AJ, Taubenberger S, Chang JC, Hacker K. Provider Perceptions of Medication for Opioid Use Disorder (MOUD) in Allegheny County Pennsylvania. Substance Abuse Journal. In Press. 2021.
